cancer clinical trials in sacramento, CA
|
University of California Davis Cancer Center
Trial Locations University of California Davis Cancer Center Kaiser Permanente Medical Center - Oakland Neuroblastoma
|
|
UC Davis Comprehensive Cancer Center
Sacramento, California 95817 HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
|
|
Kaiser Permanente
Sacramento, California Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
|
|
Radiological Associates of Sacramento Medical Group, Incorporated
Trial Locations Radiological Associates of Sacramento Medical Group, Incorporated Mercy General Hospital Prostate Cancer
|
|
UC Davis Comprehensive Cancer Center
Sacramento, California 95817 BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2), Unspecified Adult Solid Tumor, Protocol Specific
|
|
University of California Davis Cancer Center
Sacramento, California 95817 Lung Cancer
|
|
Sutter Cancer Center
Sacramento, California 95816 Leukemia
|
|
University of California Davis Cancer Center
Trial Locations University of California Davis Cancer Center Radiological Associates of Sacramento Medical Group, Incorporated Mercy General Hospital Prostate Cancer
|
|
Kaiser Permanente Medical Center - Oakland
Sacramento, California 95825 Leukemia
|
|
University of California Davis Cancer Center
Trial Locations University of California Davis Cancer Center Radiological Associates of Sacramento Medical Group, Incorporated Mercy General Hospital Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
|
|
University of California Davis Cancer Center
Trial Locations University of California Davis Cancer Center Radiological Associates of Sacramento Medical Group, Incorporated Mercy General Hospital Prostate Cancer
|
|
Kaiser Permanente
Sacramento, California Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
|
|
University of California, Davis
Sacramento, California 95818 Carcinoma, Non-Small-Cell Lung
|
|
University of California at Davis Center for Aids Research and Education Services
Sacramento, California 95814 Lymphoma
|
|
UC Davis Comprehensive Cancer Center
Sacramento, California 95817 Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
|
|
Kaiser Permanente
Sacramento, California Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
|
|
Radiological Associates of Sacramento Medical Group, Incorporated
Trial Locations Radiological Associates of Sacramento Medical Group, Incorporated Mercy General Hospital Colorectal Cancer
|
|
Sutter Medical Group
Sacramento, California 95816 Breast Cancer
|
|
University of California Davis Medical Center
Sacramento, California 95817 Hepatic Veno-Occlusive Disease
|
|
University of California Davis Cancer Center
Sacramento, California 95817 Ovarian Cancer
|
|
University of California Davis Cancer Center
Trial Locations University of California Davis Cancer Center Kaiser Permanente Medical Center - Oakland Kaiser Permanente Medical Center - Sacramento South Sacramento Kaiser-Permanente Medical Center Lung Cancer
|
|
Kaiser Permanente
Trial Locations Kaiser Permanente UC Davis Comprehensive Cancer Center Kaiser Permanente-South Sacramento Kaiser Permanente - Sacramento Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
|
|
Radiological Associates of Sacramento Medical Group, Incorporated
Trial Locations Radiological Associates of Sacramento Medical Group, Incorporated Mercy General Hospital Esophageal Cancer
|
|
University of California Davis Cancer Center
Trial Locations University of California Davis Cancer Center Kaiser Permanente Medical Center - Oakland Kaiser Permanente Medical Center - Sacramento South Sacramento Kaiser-Permanente Medical Center Lung Cancer
|
|
Kaiser Permanente
Sacramento, California Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
|
|
University of California, Davis
Sacramento, California 95818 Multiple Sclerosis, Myasthenia Gravis, Transverse Myelitis
|
|
University of California, Davis
Sacramento, California 95818 Lambert Eaton Myasthenic Syndrome
|
|
University of California, Davis Department of Dermatology
Sacramento, California 95816 Facial Dermatoses, Seborrheic Keratoses
|
|
University of California, Davis
Sacramento, California 95818 Acne, Actinic Keratosis, Dysplastic Nevi, Eczema, Psoriasis, Skin Cancer, Rosacea, Leg Ulcers, Foot Ulcers, Atopic Dermatitis
|
|
University of California at Davis Health System
Sacramento, California 95817-2307 Primary Progressive Multiple Sclerosis
|
|
UC Davis Comprehensive Cancer Center
Sacramento, California 95817 Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
|
|
UC Davis Comprehensive Cancer Center
Trial Locations UC Davis Comprehensive Cancer Center Kaiser Permanente-South Sacramento Kaiser Permanente - Sacramento Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
|
